The effect of anti-lymphocytic serum of infection by congo virus (Crimean haemorrhagic fever virus related) and Mokola virus (rabies virus related).
D000042:Absorption; D000367:Age Factors; D000818:Animals; D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D001103:Arboviruses; D001921:Brain / Q000473:pathology; D004912:Erythrocytes / Q000276:immunology; D007165:Immunosuppression Therapy; D007249:Inflammation; D008216:Lymphocytic Choriomeningitis / Q000276:immunology; D051379:Mice; D012328:RNA Viruses; D013154:Spleen / Q000473:pathology; D013163:Splenomegaly / Q000209:etiology; D013950:Thymus Gland / Q000166:cytology*; D013997:Time Factors; D014776:Virus Cultivation; D014777:Virus Diseases / Q000276:immunology* / Q000401:mortality / Q000473:pathology
D000956:Antigens, Viral; D000961:Antilymphocyte Serum